The ACP received funding to help interpret research and support decisions about MS treatments for older adults with MS.

Advances in diagnostics and disease-modifying therapies have significantly expanded treatment options for MS over the past 2 ...

A new, lifelike model of nerve fibers may serve as a platform to screen for experimental treatments that can promote myelin ...

Scientists hunting for treatments and cures for multiple sclerosis may have found an unlikely ally — the yak. The high-altitude, cold-hardy relative of the cow could be the key to a medical ...

Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ...

Were you Seen at the 2026 Together for a Cure luncheon to benefit the National Multiple Sclerosis Society on March 27, 2026, ...

MS is a chronic, immune-mediated disease affecting the central nervous system, with no known cure and varying levels of impact on individuals. Over 20 FDA-approved disease-modifying therapies exist, ...

You've probably heard of multiple sclerosis, especially if you're a fan of The West Wing. But can we ever cure MS? Yes. But ...

Key opinion leaders discuss the single FDA-approved option for primary progressive multiple sclerosis and emerging therapies under investigation for this MS subtype, examine the PERSEUS trial, and ...

"The observed differential effects of high-efficacy disease-modifying agents across sexes underscore the importance of sex-specific considerations in making treatment decisions to personalize care in ...

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022. According to the study published in ...